FDA
approval
· 2013-02-28
FDA Approved: ABILIFY MAINTENA — Original Application (Otsuka America Pharmaceutical, Inc.)
Summary
The FDA approved ABILIFY MAINTENA (aripiprazole) through an Original Application (NDA202971) from Otsuka America Pharmaceutical, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ABILIFY MAINTENA (ARIPIPRAZOLE)